Search results for "microRNA."

showing 10 items of 574 documents

Biomarkers for Prognosis and Treatment Response in COVID-19 Patients

2021

During a severe infection such as coronavirus disease 2019 (COVID-19), the level of almost all analytes can change, presenting a correlation with disease severity and survival; however, a biomarker cannot be translated into clinical practice for treatment guidance until it is proven to have a significant impact. Several studies have documented the association between COVID-19 severity and circulating levels of C-reactive protein (CRP) and interleukin-6, and the accuracy of the CRP level in predicting treatment responses has been evaluated. Moreover, promising findings on prothrombin and D-dimer have been reported. However, the clinical usefulness of these biomarkers in COVID-19 is far from …

OncologyTreatment responsemedicine.medical_specialtyCoronavirus disease 2019 (COVID-19)Clinical BiochemistryPredictive valueReview Articlemacromolecular substances030204 cardiovascular system & hematologySeverity of Illness IndexSeverityGeneral Laboratory MedicineFibrin Fibrinogen Degradation Products03 medical and health sciences0302 clinical medicineDisease severityInternal medicineSeverity of illnessHumansMedicine030212 general & internal medicineInterleukin 6biologyInterleukin-6SARS-CoV-2business.industryBiochemistry (medical)C-reactive proteinCOVID-19General MedicinePrognosisCoronavirusClinical PracticeMicroRNAsC-Reactive Proteinbiology.proteinBiomarker (medicine)businessBiomarkersAnnals of Laboratory Medicine
researchProduct

Plasma circulating miRNAs as diagnostic and prognostic biomarkers in alpha-1 antitrypsin deficiency

2019

Introduction: Alpha-1 antitrypsin (AATD) deficiency is an inherited condition that leads to decreased circulating AAT levels, significantly increasing the risk of lung and liver disease. AATD is underdiagnosed. Severity of symptoms in AATD patients are highly variable and neither protein levels nor phenotype are sufficient to identify which patients will develop lung and/or liver disease. Therefore, new strategies and biomarkers for early diagnosis and prognosis of the disease are needed. Rationale and Aims: MicroRNAs (miRNAs) regulate gene expression and have been associated with the pathogenesis of various lung and liver diseases. Circulating miRNAs may serve as diagnostic and prognostic …

Oncologymedicine.medical_specialtyAlpha 1-antitrypsin deficiencyLungbusiness.industryDiseasemedicine.diseasePhenotypePathogenesisLiver diseasemedicine.anatomical_structureInternal medicinemicroRNAGene chip analysismedicinebusinessMolecular pathology and funct. genomics
researchProduct

Differential microRNA expression in breast cancer patients aged 35 years or younger

2015

Oncologymedicine.medical_specialtyBreast cancerOncologybusiness.industryInternal medicinemicroRNAmedicineCancerHematologymedicine.diseasebusinessAnnals of Oncology
researchProduct

Circulating miR-22, miR-24 and miR-34a as novel predictive biomarkers to pemetrexed-based chemotherapy in advanced non small cell lung cancer

2013

Pemetrexed has been widely used in patients with advanced non-small cell lung cancer (NSCLC). The clinical relevance of polymorphisms of folate pathway genes for pemetrexed metabolism have not been fully elucidated yet. The aim of this study was to evaluate the expression levels of circulating miR-22, miR-24, and miR-34a, possibly involved in folate pathway, in NSCLC patients treated with pemetrexed compared with healthy controls and to investigate their impact on patient clinical outcomes. A total of 22 consecutive patients with advanced NSCLC, treated with pemetrexed-based chemotherapy and 27 age and sex matched healthy controls were included in this preliminary analysis. miR-22, miR-24, …

Oncologymedicine.medical_specialtyChemotherapyPhysiologybusiness.industrymedicine.medical_treatmentClinical BiochemistryCellCell BiologyBioinformaticsmedicine.diseasemedicine.anatomical_structurePemetrexedInternal medicinemicroRNAmedicineClinical significancebusinessLung cancerProgressive diseaseWhole bloodmedicine.drugJournal of Cellular Physiology
researchProduct

Diagnostic and prognostic value of three micrornas in environmental asbestiform fibers-associated malignant mesothelioma

2021

Fluoro-edenite (FE) is an asbestiform fiber identified in Biancavilla (Sicily, Italy). Environmental exposure to FE has been associated with a higher incidence of malignant mesothelioma (MM). The present study aimed to validate the predicted diagnostic significance of hsa-miR-323a-3p, hsa-miR-101-3p, and hsa-miR-20b-5p on a subset of MM patients exposed to FE and matched with healthy controls. For this purpose, MM tissues vs. nonmalignant pleura tissues were analyzed through droplet digital PCR (ddPCR) to evaluate differences in the expression levels of the selected miRNAs and their MM diagnostic potential. In addition, further computational analysis has been performed to establish the corr…

Oncologymedicine.medical_specialtyFluoro-edenitediagnosisMedicine (miscellaneous)AsbestoAsbestiformmedicine.disease_causeAsbestosArticleInternal medicinemicroRNAmedicineDigital polymerase chain reactionMesotheliomaMalignant mesotheliomaReceiver operating characteristicbusiness.industryIncidence (epidemiology)RMicroRNAEnvironmental exposuremedicine.diseaseasbestosPrognosisMedicinebusinessDiagnosi
researchProduct

Early detection of lung cancer in exhaled breath condensate using miRNA markers

2015

Background: Lung cancer is the leading cause of death by cancer worldwide. Since 5-year survival rate increases significantly when lung cancer is diagnosed at early stages, the development of accurate non-invasive biomarkers for early lung cancer diagnosis is of utmost importance. Over the last years, several tumour biomarkers based on microRNAs (miRNAs) determined in exhaled breath condensate (EBC) have been evaluated and could be applied to early diagnosis of lung cancer. Rationale: miRNA signatures for surgical specimens of lung cancer have been determined providing a panel of differentially expressed miRNAs that were able to discriminate lung cancer patients from normal subjects. Using …

Oncologymedicine.medical_specialtybusiness.industryCancerEarly detectionDifferentially expressed mirnasrespiratory systemmedicine.diseaserespiratory tract diseasesInternal medicinemicroRNAMedicineExhaled breath condensatebusinessLung cancerSurvival rateCause of death11.1 Lung Cancer
researchProduct

Upregulated Mirna 21 in Kras Mutated Patients is Related to Prognosis in Resectable Non-Small Cell Lung Cancer

2015

Oncologymedicine.medical_specialtybusiness.industryHematologymedicine.diseasemedicine.disease_causeOncologyInternal medicineMutation (genetic algorithm)microRNAmedicineNon small cellKRASbusinessLung cancerAnnals of Oncology
researchProduct

MicroRNAs and their role in the malignant transformation of oral leukoplakia: a scoping review

2021

Background MiRNAs are small non-coding RNAs that regulate gene expression at the post-transcriptional level and have been associated with malignant transformation of oral epithelial precursor lesions such as oral leukoplakia. The aim was to perform a scoping review of the contemporary literature about the different roles of miRNAs during the malignant transformation of oral leukoplakia. Material and Methods We conducted a systematic search with the following MeSH terms: ‘oral leukoplakia’, ‘carcinoma in situ’, ‘microRNAs’, ‘mouth neoplasms’ and ‘epithelial–mesenchymal transition’ in PubMed/MEDLINE, EMBASE and SpringerLink. Results Fifteen articles were included for analysis, among which in …

Oncologymedicine.medical_specialtycone-beam computed tomographyMEDLINEReviewMalignant transformationstomatognathic systemOral Cancer and Potentially malignant disordersInternal medicinemicroRNAmedicineHumansProspective StudiesProspective cohort studyGeneral DentistryUNESCO:CIENCIAS MÉDICASsalivary gland calculiMouth neoplasmMesh termbusiness.industryCarcinoma in situmedicine.diseaseobserver variationOral leukoplakiaMicroRNAsstomatognathic diseasesCell Transformation NeoplasticOtorhinolaryngologyMouth NeoplasmsSurgeryLeukoplakia OralbusinessMedicina Oral Patología Oral y Cirugia Bucal
researchProduct

Circulating miR-99a-5p Expression in Plasma: A Potential Biomarker for Early Diagnosis of Breast Cancer

2020

MicroRNAs have emerged as new diagnostic and therapeutic biomarkers for breast cancer. Herein, we analysed miR-99a-5p expression levels in primary tumours and plasma of breast cancer patients to evaluate its usefulness as a minimally invasive diagnostic biomarker. MiR-99a-5p expression levels were determined by quantitative real-time PCR in three independent cohorts of patients: (I) Discovery cohort: breast cancer tissues (n = 103) and healthy breast tissues (n = 26)

Oncologymedicine.medical_specialtydiagnosisDown-RegulationBreast NeoplasmsReal-Time Polymerase Chain ReactionArticleCatalysislcsh:ChemistryInorganic Chemistrybreast cancerBreast cancerInternal medicinemicroRNABiomarkers TumorHumansMedicineDiagnostic biomarkerCirculating MicroRNAPhysical and Theoretical Chemistryskin and connective tissue diseaseslcsh:QH301-705.5Molecular BiologyEarly Detection of CancerplasmaSpectroscopyRetrospective StudiesEarly breast cancerPlasma samplesbusiness.industryOrganic ChemistryGeneral MedicineMiddle Agedmedicine.diseaseComputer Science ApplicationsGene Expression Regulation NeoplasticMicroRNAsROC Curvelcsh:Biology (General)lcsh:QD1-999Potential biomarkersCohortbiomarkerBiomarker (medicine)FemalebusinessInternational Journal of Molecular Sciences
researchProduct

New molecular targets for the treatment of osteoarthritis.

2009

Osteoarthritis (OA) is a chronic degenerative joint disorder characterized by destruction of the articular cartilage, subchondral bone alterations and synovitis. Current treatments are focused on symptomatic relief but they lack efficacy to control the progression of this disease which is a leading cause of disability. Therefore, the development of effective disease-modifying drugs is urgently needed. Different initiatives are in progress to define the molecular mechanisms involved in the initiation and progression of OA. These studies support the therapeutic potential of pathways relevant in joint metabolism such as Wnt/beta-catenin, discoidin domain receptor 2 or proteinase-activated rece…

OsteoarthritisBioinformaticsBiochemistryModels BiologicalSynovitismicroRNAOsteoarthritismedicineAnimalsHumansbeta CateninPharmacologybusiness.industryCartilageADAMTSWnt signaling pathwayGenetic Therapymedicine.diseaseSymptomatic reliefWnt ProteinsMicroRNAsmedicine.anatomical_structureFrzbImmunologyCytokinesIntercellular Signaling Peptides and ProteinsbusinessBiochemical pharmacology
researchProduct